Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer — Stella

Home/Metastatic Prostate Adenocarcinoma/Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Prostate Adenocarcinoma trials

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Trial locations(1 site)

Finland

Kuopio University Hospital, Kuopio, Northern Savonia

Key details

Sponsor

Kuopio University Hospital

Collaborators

University of Eastern Finland

Enrollment target

~150 participants

Started

January 2020

Primary completion

December 2030

Age range

18 Years and older

Sex

Male only

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.